Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia

Affiliations

• ¹ Department of Clinical Analysis and Immunology, UGC Clinical Laboratory, Institute of Biosanitary Research ibs.Granada, University of Granada Hospital Complex, Granada, Spain.
• ² Tumor Immunology Laboratory, Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA.
• ³ Agenus Inc., Lexington, MA, USA.
• ⁴ Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
• ⁵ Skin Cancer Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. v.umansky@dkfz.de.
• ⁶ Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany. v.umansky@dkfz.de.